Does diabetes therapy influence the risk of cancer?
- 14 July 2009
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 52 (9), 1699-1708
- https://doi.org/10.1007/s00125-009-1441-5
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology GroupDiabetologia, 2009
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort studyDiabetologia, 2009
- Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label studyDiabetologia, 2009
- Enhancing CD8 T-cell memory by modulating fatty acid metabolismNature, 2009
- Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 DiabetesDiabetes, 2009
- Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysisCMAJ : Canadian Medical Association Journal, 2009
- Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes MellitusJama-Journal Of The American Medical Association, 2008
- Glargine blood biotransformation: in vitro appraisal with human insulin immunoassayDiabetes & Metabolism, 2007
- The Role of Obesity and Related Metabolic Disturbances in Cancers of the Colon, Prostate, and PancreasGastroenterology, 2007
- The Hallmarks of CancerCell, 2000